TIFFANY TRICHEL: Open Payments
NPI 1437803715 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 10 payments from 9 companies in 2025. Trend: 2023 $553 · 2024 $1,326 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $137 |
| Corcept Therapeutics | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 2 | $109 |
| Edwards Lifesciences Corporation | 1 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $96 |
| Sumitomo Pharma America, Inc. | 1 | $71 |
Products named: EVENITY, Korlym, Symbravo, KISUNLA, SAPIEN 3 Ultra RESILIA, Kerendia, GEMTESA, FARXIGA.
Industry payments across TX — which companies pay providers there.
